[1] 邹筱芳,巫冠中.尿酸肾损伤的分子机制研究进展[J].安徽医药,2015,19(1):5-9.
[2] WANG J, CHEN R P, LEI L, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China[J].Asia Pacific Journal of Clinical Nutrition,2013,22(4):590-598.
[3] KRISHNAN E. Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: nhanes 2009-2010[J].Journal of the American Heart Association,2014,3(2):e000 157-e000 157.
[4] YOU L L, LIU A P, WUYUN G W, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area[J]. Journal of Atherosclerosis and Thrombosis,2014,21(4):355-365.
[5] GUSTAFSSON D, UNWIN R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality[J]. BMC Nephrology,2013,14(1):164.
[6] CHEN S, GUO X, DONG S, et al. Association between the hypertriglyceridemic waist phenotype and hyperuricemia:A cross-sectional study[J].Clinical Rheumatology,2017,36(5):1 111-1 119.
[7] 马金魁,张宏斌.高尿酸血症及治疗药物的研究进展[J].广东医学,2018,39(s2):262-267.
[8] 王朝晖,苏冠华.临床用药速查手册[M].北京:中国协和医科大学出版社,2009.
[9] 曹启江,宋庆凤,姚满,等.治疗痛风新型药物研究进展[J].广东医学,2019,40(10):1 497-1 500.
[10] 艾国,杜丽娜,梅兴国.蛋白质、多肽类药物新剂型与新技术发展动态[J].中国生化药物杂志,2004,25(6):366-369.
[11] 吴建中,赵谋明,宁正祥.食品中的生物活性多肽[J].食品与发酵工业,2002,28(11):46-50.
[12] 王成华,邢新会.黄嘌呤氧化酶的研究进展及其发展前景[J].广西科学,2017,24(1):15-24.
[13] 刘晓然,李泰明.黄嘌呤氧化酶抑制剂在高尿酸血症治疗中的研究进展[J].轻工科技,2017,33(9):20-21.
[14] 赵莹, 张启虹, 冯明声, 等. 降尿酸药物黄嘌呤氧化酶抑制剂的研究进展[J]. 药学进展, 2009, 33(2):55-61.
[15] 黎青勇.核桃源降尿酸肽靶向抑制黄嘌呤氧化酶活性的构效机制研究[D].广州:华南理工大学,2018.
[16] NONGONIERMA A B, FITZGERLD R J. Tryptophan-containing milk protein-derived dipeptides inhibit xanthine oxidase[J]. Peptides, 2012, 37(2):263-272.
[17] NONGONIERMA A B, MOONEY C, SHIELDS D C, et al. Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides[J]. Food Chemistry, 2013, 141(1):644-653.
[18] 刘洋.海洋鱼抗痛风肽的制备及其作用机理研究[D].广州:华南理工大学,2014.
[19] 张开平,苏仕林,刘燕丽,等.生物活性肽功能及制备方法的研究进展[J].农产品加工,2015(12):61-64.
[20] SU X, DONG C, ZHANG J, et al. Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer[J].Cell and Bioscience, 2014,4(1):1-13.
[21] 阮晓慧,韩军岐,张润光,等.食源性生物活性肽制备工艺、功能特性及应用研究进展[J].食品与发酵工业,2016,42(6):248-253.
[22] 刘铭,刘玉环,王允圃,等.制备、纯化和鉴定生物活性肽的研究进展及应用[J].食品与发酵工业,2016,42(4):244-251.
[23] LI Q Y, KANG X Y, SHI C C, et al. Moderation of hyperuricemic rats via consuming walnut protein hydrolysates diet and identification of new antihyperuricemic peptides[J].Food and Function.2018, 9(1):107-116.
[24] LIU N X, WANG Y, YANG M F, et al. New rice-derived short peptide potently alleviated hyperuricemia induced by potassium oxonate in rats [J]. Journal of Agricultural and Food Chemistry,2019,67(1):220-228.
[25] JANG I T, HYUN S H, SHIN J W, et al. Characterization of an anti-gout xanthine oxidase inhibitor from Pleurotus ostreatus[J]. Mycobiology,2014,42(3):296-300.
[26] 盛周煌.罗非鱼皮胶原蛋白降尿酸活性肽的研究[D].广州:华南理工大学,2018.
[27] 邹琳.鲣鱼黄嘌呤氧化酶抑制肽的酶解制备及功能活性评价[D].杭州:浙江大学,2019.
[28] LI Y J, KANG X Y, LI Q Y, et al. Anti-hyperuricemic peptides derived from bonito hydrolysates based on in vivo hyperuricemic model and in vitro xanthine oxidase inhibitory activity[J].Peptides,2018,107:45-53.
[29] MUROTA I, TAGUCHI S, SATO N, et al. Identification of antihyperuricemic peptides in the proteolytic digest of shark cartilage water extract using in vivo activity-guided fractionation[J].Journal of Agricultural and Food Chemistry,2014, 62(11):2 392-2 397.
[30] HE W W, SU G W, SUN D X, et al. In vivo anti-hyperuricemic and xanthine oxidase inhibitory properties of tuna protein hydrolysates and its isolated fractions[J].Food Chemistry,2019,272:453-461.
[31] 赵谋明,徐巨才,刘洋,等.秋刀鱼制备黄嘌呤氧化酶抑制肽的工艺优化[J].农业工程学报,2015,31(14):291-297.
[32] 白雪,李丹凤,王婷婷,等.发酵法制备生物活性肽及其产物的初步分析[J].食品工业科技,2013,34(23):201-205.
[33] MUROTA I, TAMAI T, BABA T, et al. Uric acid lowering effect by ingestion of proteolytic digest of shark cartilage and its basic fraction[J].Journal of Food Biochemistry,2010,34(1):182-194.
[34] YU L, YANG L, AN W, et al. Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells[J].Journal of Cellular Biochemistry,2014,115(4):697-711.
[35] LI Q Y, SHI C C, WANG M, et al. Tryptophan residue enhances in vitro walnut protein-derived peptides exerting xanthine oxidase inhibition and antioxidant activities[J].Journal of Functional Foods,2019,53(53):276-285.
[36] 任娇艳,康小燕.一种具有降尿酸活性的多肽及其应用:中国,106317178A[P].2017-01-11.
[37] 杨方威,冯叙桥,曹雪慧, 等.膜分离技术在食品工业中的应用及研究进展[J].食品科学,2014,35(11):330-338.
[38] 王志斌,杨宗伟,邢晓林,等.膜分离技术应用的研究进展[J].过滤与分离,2008,18(2):19-23.
[39] 苏国万,赵谋明,赵强忠,等.一种用核桃粕制备具有降尿酸功效的生物活性肽的方法:中国,103627760A[P].2014-03-12.
[40] 刘丹,任娇艳,梁明.高尿酸血症细胞模型的构建及其在降尿酸肽筛选中的应用[J].现代食品科技,2017,33(8):72-79.
[41] 杨柳,康小燕,梁明,等.筛选降尿酸肽的体外测定方法的建立与优化[J].现代食品科技,2018,34(4):249-257.
[42] 康小燕. 磁性微球固定化黄嘌呤氧化酶的制备及其分离降尿酸肽的研究[D].广州:华南理工大学,2017.
[43] 王晗,张敏,路腾飞,等.高尿酸血症动物模型研究进展[J].天津中医药大学学报,2014,33(4):253-256.
[44] 刘静,徐玲玲.常用痛风模型的作用机制及评价[J].中国药师,2012,15(8):1 193-1 194.
[45] 杨会军,李兆福,彭江云.高尿酸血症动物模型研究概况[J].中医学报,2013,28(1):60-62.
[46] 马思佳,霍娇,张立实.高尿酸血症动物模型研究进展[J].卫生研究,2015,44(1):158-162.
[47] PINEDA C, FUENTES-GMEZ, ARTURO J, et al. Animal model of acute gout reproduces the inflammatory and ultrasonographic joint changes of human gout[J]. Arthritis Research and Therapy,2015,17(1):37.
[48] SANTOS R M S, OLIVEIRA S M, SILVA C R, et al. Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats[J].Inflammation Research,2013,62(6):617-625.
[49] 费洪新,韩玉生,廖婷,等.车前子对小鼠急性痛风性关节炎的影响[J].黑龙江科学,2014,5(5):9-11.
[50] KUBENA L F, PHILLIPS T D, CREGER C R, et al. Toxicity of ochratoxin A and tannic acid to growing chicks[J]. Poultry Science,1983,62(9):1 786-1 793.
[51] 孙婷婷,李妍妍,周君,等.仿刺参酶解液抑制黄嘌呤氧化酶活性的研究[J].中国食品学报,2019,19(7):128-137.
[52] 石拓,卢存龙,李龙,等.液相色谱-质谱研究高尿酸血症大鼠血清代谢组学[J].基础医学与临床,2019,39(3):337-342.
[53] 孙敏.蜂毒活性肽的分离纯化及生理功能研究[D].济南:济南大学,2017.
[54] 张锐,姚芳芳,何伟.酪蛋白磷酸肽、钙粉及二者复合物对高尿酸血症大鼠的影响[J].食品科学, 2010, 31(21):332-334.
[55] ASHA K K, REMYA-KUMARI K R, ASHOK-KUMAR K, et al. Sequence determination of an antioxidant peptide obtained by enzymatic hydrolysis of oyster Crassostrea madrasensis (Preston)[J].International Journal of Peptide Research and Therapeutics, 2016, 22(3):421-433.